SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-17-008271
Filing Date
2017-08-28
Accepted
2017-08-28 15:54:02
Documents
11

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 69816
2 filename2.htm EX-10 227207
3 filename3.htm EX-10 202758
4 filename4.htm EX-10 84844
5 GRAPHIC g412784g02k68.jpg GRAPHIC 4714
6 GRAPHIC g412784g20a74.jpg GRAPHIC 5332
7 GRAPHIC g412784g27g05.jpg GRAPHIC 4567
8 GRAPHIC g412784g44r34.jpg GRAPHIC 2515
9 GRAPHIC g412784g56h25.jpg GRAPHIC 5048
10 GRAPHIC g412784g85c85.jpg GRAPHIC 6173
11 GRAPHIC g412784g97e84.jpg GRAPHIC 4469
  Complete submission text file 0000950123-17-008271.txt   631891
Mailing Address 81 HARTWELL AVE. SUITE 100 LEXINGTON MA 02421
Business Address 81 HARTWELL AVE. SUITE 100 LEXINGTON MA 02421 646-522-8445
Nightstar Therapeutics Ltd (Filer) CIK: 0001711675 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-01636 | Film No.: 171054635
SIC: 2836 Biological Products, (No Diagnostic Substances)